When customs seizes a peptide package: what the rules say

How a peptide package reaches FDA

A package from abroad goes first to a postal sorting facility or an express courier's hub. US Customs and Border Protection examines incoming mail and courier shipments and refers products FDA regulates, including drugs, to FDA for review (government guidance) ¹. FDA's import staff then decide whether the product can be admitted. Most packages pass through without anyone opening them; the ones that are flagged are where the rules below come in. Being flagged once does not mean every later parcel will be, and getting one through says nothing about the next.

A peptide powder labelled 'research use only', a vial of semaglutide from an overseas seller, or capsules of BPC-157 are all drugs for this purpose, because of what they are and how they are used. Our guide to what 'research use only' means explains why that label does not change their regulatory status.

The starting rule: importing unapproved drugs is illegal

FDA states the default plainly: in most circumstances it is illegal for individuals to import drugs into the US for personal use, because drugs bought abroad often are not FDA-approved, and a drug approved in another country but not in the US is an unapproved new drug here (government guidance) ². The Congressional Research Service puts it the same way: current law generally prohibits importing unapproved new drugs, including foreign-made versions of FDA-approved drugs (policy analysis) ³.

That covers most of what is sold as research peptides. BPC-157, TB-500 and similar compounds have no approval anywhere in the US system; foreign-made semaglutide or tirzepatide, even of good quality, is an unapproved version of an approved drug. Our BPC-157 and retatrutide entries record each compound's status.

What the personal importation policy actually allows

FDA has a personal importation policy, but it is guidance on when the agency may choose not to act, not a right to import. FDA lists two situations where its staff may be more permissive. One is a product that is not for a serious condition and carries no known significant health risk. The other is a prescription drug for a serious condition, where all of the following apply: effective treatment may not be available in the US through commercial or clinical means; there is no known commercialisation or promotion of the product to US residents; it does not present an unreasonable risk; the consumer affirms in writing that it is for personal use; the quantity is generally no more than a three-month supply; and the person provides the name and address of a US-licensed doctor responsible for the treatment, or evidence that it continues treatment begun abroad (government guidance) ².

The Congressional Research Service adds that the policy was not intended as a way for consumers to bring in cheaper versions of drugs available in the US, but to allow access to treatments not otherwise available here (policy analysis) ³.

Why research peptides rarely fit

Set those conditions against a typical peptide order and the problems are obvious. Most research peptides are bought for wellness, recovery or weight loss rather than a serious condition lacking any domestic treatment; weight loss, for example, has approved US drugs. Many are actively promoted to US residents by the sellers themselves, which fails the no-commercialisation condition. Few buyers have a US doctor who is responsible for treating them with the product. And an unapproved peptide of unknown purity can be judged an unreasonable risk.

FDA also lists when it would refuse a personal importation: when the product is on an FDA import alert for previous violations, when the shipment appears intended for commercial distribution, when the product appears to present a serious health risk, or when it appears to represent health fraud (government guidance) ². Large quantities, multiple vials of the same compound, or shipments from suppliers already flagged can all point toward refusal.

What a Notice of FDA Action means

If FDA decides a shipment appears to violate the law, it sends a Notice of FDA Action, also called a notice of detention and hearing. FDA says the notice explains why the product is subject to refusal, that it would be destroyed if refused, and that you have an opportunity to present testimony before refusal or destruction, with an FDA contact, usually a compliance officer, to respond to (government guidance) ¹.

The 'hearing' is less formal than it sounds. FDA describes it as anything from a series of emails or phone calls to a more formal meeting, in which you can submit evidence to overcome the appearance of a violation. FDA then issues a second notice: either the product is released and forwarded to you, or it is refused, with the reasons and whether it will be destroyed or returned to the sender (government guidance) ¹.

If you do not respond at all, FDA says the product will be processed for destruction (government guidance) ¹.

Should you respond?

That depends on whether you can show the shipment meets the personal importation conditions. For an approved drug prescribed by a US doctor, or a medicine you began taking legitimately abroad, a response with the prescription, the doctor's details and a written personal-use statement addresses what FDA looks for. For a research peptide with no approval and no treating doctor, there is usually nothing that would overcome the violation, because the product is unapproved and not for a condition lacking US treatment.

This article is not legal advice. If the stakes are high, for example a business shipment, a large value or a controlled substance, a lawyer who handles FDA import matters is the right person to ask. Controlled substances are handled with the DEA rather than FDA alone, under stricter rules (government guidance) ².

Destruction without the option to send it back

Since 2016 FDA has been able to destroy refused drugs valued at $2,500 or less that arrive through international mail or express couriers, without giving the owner the option to export them. The power comes from section 708 of the Food and Drug Administration Safety and Innovation Act of 2012, and a 2024 rule extended a similar power to devices (government guidance) ¹.

As of March 2026, FDA says the owner or consignee is legally responsible for storage and destruction costs, but that it generally does not intend to pursue those costs from individual consumers importing for their own use. Shipments worth more than $2,500 are generally treated by CBP as formal entries with different procedures, including a bond (government guidance) ¹.

FDA's reasons for destroying rather than returning such products are spelled out on the same page: unapproved drugs from foreign sources have been found contaminated, counterfeit, with varying amounts of active ingredient, different active ingredients, or none at all. FDA also notes that the lack of an English-language label can indicate a misbranded drug, and that its staff may sample products for testing (government guidance) ¹.

Beyond losing the package

For an individual importing a small personal quantity, the usual outcome of a refusal is losing the product and the money paid for it. FDA's pages describe refusal and destruction, not penalties for individual consumers, and say it generally will not seek costs from them (government guidance) ¹. But the picture changes with quantity and intent: shipments that look commercial are treated as such, and selling unapproved drugs is a federal offence.

A former FDA official now at the US Anti-Doping Agency told the Associated Press in December 2025 that the law governing these products dates to 1938 and is not working well against online sales (news report) ⁴. Enforcement at the border is one of the few points where the system does catch these products, which is why seizures happen even when sellers promise discreet delivery. Tested athletes and service members face separate rules on use and possession, whatever happens to the package.

Discreet shipping and relabelled boxes

Some overseas sellers promise discreet packaging, or describe peptides on customs forms as cosmetics, chemicals or gifts. That does not change what the product is. FDA identifies violative drugs partly from labelling and partly by sampling and testing, and notes that a label not in English can itself indicate a misbranded drug (government guidance) ¹. A shipment whose declared contents do not match what is inside invites a closer look rather than avoiding one.

It also leaves the buyer with even less to go on if the package does arrive: a box declared as one thing and labelled as another tells you nothing reliable about what is in the vial.

What a successful delivery does not tell you

A package that gets through customs has not been checked, approved or found safe; it simply was not stopped. When researchers bought semaglutide from illegal online pharmacies, the vials that arrived had purity of 7.7% to 14.4% against the 99% claimed and endotoxin in every sample, and the pens ordered never arrived (market surveillance study) ⁵. Our article on group buys and testing covers what independent tests have found and what a certificate of analysis cannot tell you.

The lawful alternatives

For approved peptide drugs, the lawful route is a prescription from a licensed clinician and a licensed US pharmacy; our guide to legitimate prescriptions explains how to check both. For a medicine you were prescribed abroad and need to continue, FDA's policy allows for a three-month supply with evidence that treatment began there, and foreign nationals visiting the US may bring or ship a 90-day supply of their own medication (government guidance) ².

For unapproved peptides, there is no lawful import route for personal use that the policy reliably covers. Our regulatory tracker follows each compound's US status, including the compounding decisions that would create a domestic route if FDA acts on its advisers' votes.

Common questions about notices

• Will I be arrested for one seized package? FDA's import pages describe refusal and destruction of personal shipments, not penalties for individual consumers; commercial-scale shipments are a different matter.
• Can I ask for it to be sent back? As of October 2026, for refused drugs worth $2,500 or less arriving by mail or courier, FDA can destroy them without offering export.
• Will I be charged? The law makes the owner responsible for storage and destruction costs, but FDA says it generally does not pursue them from individual consumers.
• Does the seller's 'reship guarantee' mean anything? Only that the seller will try again; it does not change the law.

Small packages are no longer duty-free

A separate change affects every small overseas order, peptides included. Under an Executive Order of July 30, 2025, CBP stopped granting duty-free 'de minimis' treatment to low-value goods from all countries from August 29, 2025. Shipments that used to clear duty-free regardless of value now need an appropriate customs entry and payment of applicable duties, taxes and fees; for packages sent through the international postal network, the carriers must collect and remit the duties to CBP (government guidance) ⁶.

For peptide buyers this matters in two ways. Small parcels now generate customs paperwork they did not before, which adds another point at which a shipment's contents are declared and can be questioned. Neither change makes an unapproved drug admissible: paying duty on a package does not answer FDA's question of whether it may enter at all. Tariff rules have shifted several times since 2025, so CBP's current guidance is the place to check the details.

What an import alert is

An import alert is FDA's way of telling its border staff that products from a particular firm, country or category have violated the law before and can be detained without physically examining each shipment. FDA lists a product being on an import alert as one of the reasons it would refuse a personal importation (government guidance) ². In practice that means a buyer can have a package refused because of what the seller shipped to other people, not anything about the buyer's own order.

Sellers rarely mention this, but it is one reason the same supplier's parcels may be stopped repeatedly while another's get through. It is not a judgment on any single box; it is FDA acting on a pattern, and a buyer has no way to see in advance whether a seller is covered by one.

Before you order from abroad

• Is the product an approved drug in the US? If not, importing it is illegal in most circumstances.
• Do you have a serious condition, a US doctor responsible for your treatment with it, and no effective US alternative? Those are the policy's conditions.
• Is the seller promoting the product to US buyers? That alone undercuts the personal-use exception.
• Are you ordering more than a three-month supply, or several vials of the same compound? That can look commercial.
• Are you willing to lose the money if the package is refused and destroyed?

How it adds up (as of October 4, 2026)

Importing unapproved drugs, including research peptides and foreign-made versions of approved drugs, is illegal in most circumstances, and FDA's personal importation policy is discretion limited to serious conditions without US treatment, under conditions most peptide orders do not meet. A detained shipment brings a Notice of FDA Action and a chance to respond; silence means destruction, and refused drugs worth $2,500 or less arriving by mail or courier can be destroyed without the option to return them. A package that arrives has not been checked, and the lawful route for approved peptides runs through a US prescription and pharmacy.

Frequently asked questions

Is it legal to import peptides for personal use?

In most circumstances, no. FDA says importing unapproved drugs for personal use is illegal; its personal importation policy is limited discretion for serious conditions without US treatment.

What is a Notice of FDA Action?

A notice that FDA has detained your shipment, explaining why it may be refused and destroyed, and giving you a contact and a chance to submit evidence.

What happens if I ignore the notice?

FDA says that if you do not respond or request a hearing, the product will be processed for destruction.

Can FDA destroy my package?

Yes. As of October 2026, refused drugs valued at $2,500 or less arriving by international mail or express courier can be destroyed without the option of export.

Will I have to pay for destruction?

The owner is legally responsible for the costs, but FDA says it generally does not pursue them from individuals importing for personal use.

Related on Grey Peptides

• What 'research use only' means
• Peptides on Amazon, Temu and TikTok Shop
• Legitimate prescriptions and red flags
• Regulatory tracker

Sources

1. U.S. Food and Drug Administration. Administrative Destruction Authority (Import Basics), content current as of March 16, 2026; read October 4, 2026. Source
2. U.S. Food and Drug Administration. Personal Importation (Import Basics), content current as of August 18, 2025; read October 4, 2026. Source
3. Congressional Research Service. Prescription Drug Importation (In Focus IF11056); read October 4, 2026.
4. Pells, E. "Doping at your doorstep: The next Olympic drug crisis could be coming through the mail." Associated Press, December 2, 2025 (syndicated text read October 4, 2026).
5. Ashraf, A. R., et al. (2024). Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. J Med Internet Res, 26, e65440. PMID: 39509151
6. U.S. Customs and Border Protection. CSMS # 66065494, Guidance: Suspension of Duty-Free De Minimis Treatment for All Countries (implementing the Executive Order of July 30, 2025, effective August 29, 2025); read October 4, 2026.

Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.